F2X-32815-92671
3 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 852 / AZ
- Registered
- 2021-04-19
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-04-19
Registered in v-safe
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-21
- 2021-10-18
-
2021-10-30
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-04-19
- 2022-04-30
-
2022-10-30
Survey response — 12 months, dose 3MedDRA: Cough, Gastroenteritis viral, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Coughing, sneezing, stomach virusMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-10-30 | Pfizer-BioNTech | Flu |
Free text
Release 12 — 12 months, dose 3
Symptoms: Coughing, sneezing, stomach virus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release